Today is the date of Anthem Biosciences’ first public offering. Analysts predict a robust share launch on the Indian stock market today ahead of Anthem Biosciences’ IPO GMP listing.
All eyes on Anthem Biosciences as it lists today. Analysts foresee strong investor demand and performance.
IPO Listing for Anthem Biosciences: Today, Anthem Biosciences shares are scheduled to launch on the Indian stock exchange. Anthem Biosciences’ IPO listing date is today, and the specialist fermentation-based APIs manufacturer’s IPO had tremendous interest throughout its subscription period.
The Anthem Biosciences IPO allotment date was July 17, and the public offering was available from July 14 to July 16. Today, July 21, 2025, is the day of Anthem Biosciences’ first public offering. Today, Anthem Biosciences’ stock will be launched on the BSE and NSE stock markets.
A notification on the BSE stated, “Trading Members of the Exchange are hereby informed that the equity shares of Anthem Biosciences Limited shall be listed and admitted to dealings on the Exchange in the list of ‘B’ Group of Securities with effect from Monday, July 21, 2025.”
It further said that Anthem Biosciences shares will be traded starting at 10:00 AM on Monday, July 21, 2025, during the Special Pre-open Session (SPOS).
Investors keep an eye on the grey market premium (GMP) movements ahead of Anthem Biosciences’ IPO filing today in attempt to predict the shares’ expected listing price.
Analysts predict that Anthem Biosciences’ IPO GMP today will see a robust share debut on the Indian stock exchange. The following is what Anthem Biosciences’ IPO GMP shows:
Today’s Anthem Biosciences IPO GMP
With a significant gray market premium, Anthem Biosciences’ shares continue to show optimistic tendencies in the unlisted market. Experts in the stock market estimate that Anthem Biosciences’ IPO GMP is ₹177 per share today. This shows that shares of Anthem Biosciences are trading on the grey market at ₹177 per, which is more than their issue price of ₹570.
Listing Price for Anthem Biosciences’ IPO
According to Anthem Biosciences’ IPO GMP today, the anticipated listing price of Anthem Biosciences shares would be ₹747 each, 31.05% more than the IPO price of ₹570 per share.
Additionally, analysts anticipate that Anthem Biosciences’ stock will list on stock markets at a significant premium to its issue price.
It is anticipated that Anthem Biosciences will have a successful first public offering on stock platforms. The shares indicate a possible listing in the region of ₹700 or higher, translating into a premium of about 20–25%, given the strong investor demand during the IPO, especially from institutional investors, stated Mahesh M. Ojha, AVP-Research & Business Development, Hensex Securities Pvt. Ltd.
He says a premium listing is sensible from a basics standpoint.
